Member Info for don_vercetti

If we estimate that one of these units costs £50k per unit, which is fairly conservative, then this order is worth ~£1.25m. Quite substantial!

It looks like Mr Market has been reassured by the recent leadership changes and is prepared to put some wind back in it's sails.

They obviously had an awful run since their IPO, as a result of youthful over-optimism and the realities of listing during the peak of Covid mania, but their gradual recovery from a low of 0.9p in July 2023 to 4.8p paid in mid October 2025 says all that needs to be said about the companies development since then. With their first operational profit in H1 2025 on revenue of £5.1m and rapidly growing PFP contributions it's hard to believe their market cap of £15.3m considering their future prospects.

They will be scaling this up quickly to lots of small contracts, in isolation they won't be large deals but they'll add up to something substantive quite quickly

This was posted last Friday to LinkedIn. I am at a loss to understand why they don't share this kind of news as an RNS as well!

3DX-RAY Ltd have announced at Intersec the sale of a follow-on order for a ThreatScan® system for EOD operations in Ukraine. This sale is a double-digit order from an unnamed customer for units deployed on operations in that conflict zone.

Of the ThreatScan® systems on show this year is the 3DX-RAY ThreatScan®-AS1(ISC) portable X-Ray System and the latest AS2 panel. https://lnkd.in/exfNsnAi

This is ripping today, up to 3.1p. We should be receiving a full year pre-close trading update soon (10th Oct or thereabouts), I wonder if it's going to contain some good news.

Exciting acquisition news this morning! Interesting to note that they're based in Detroit...I wonder whether there are plans afoot to open another branch in Texas?

Looks like Opti choosing to raise money via a fundraise, rather than selling lots of SBTX shares, has relieved the SP of some downwards pressure

A small but possibly significant RNS over at Opti today:

"OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, announces that Graham Myers has been appointed as Finance Director of the Company as of 1 December 2023.

Graham is a member of the Institute of Chartered Accountants in England & Wales and has extensive financial and commercial experience in a number of private and public companies, including being a member of the Executive Committee at Croda International Plc, where he worked for almost 30 years. Graham brings extensive experience in optimising financial controls, managing budgets, building profitable businesses and mergers & acquisitions. Graham is currently Chair of Croda Pension Trustees Limited, the sole trustee of Croda's £800m UK pension scheme."

This strengthens significantly the relationship between "Biotix" & Croda groups significantly! I can't imagine this is an appointment that happened in a vacuum.

Between a forecasted return to profitability (due to be confirmed in early December), the significant sales and their constant presence at trade shows during these times of heightened security awareness, the steady climb in share price over the last few weeks suggests there's some excitement brewing here

The time to buy is when there's blood in the water...

Like many others I'm perplexed but the market seems to like it

So I get that IIG has bought a chinese lottery company called Hui10 Inc which is valued at $365m, but the rest of the announcement is Greek to me - can anyone explain it in simple terms?

You mean BDO seems asleep as usual hehe

So for the bargain price of £2.1m Octopus Investments now own 23.37% of the company...I wonder if they see any synergies between Haydale's underfloor heating and Octopus Energy...

Not sure what all the insiders were fretting about, these results are as expected after the resolved H1 issues. Good to see that despite it all, revenue has continued to grow.

With reiteration of a further contract win to be announced, PCP up to £420m and H2-2023 revenues expected to be significantly higher it looks like Knowsley is starting to come right.

"haydale (aim: hayd) and petronas technology ventures sdn bhd (ptvsb), the technology commercialisation arm of petroliam nasional berhad (petronas), have executed a collaboration agreement to functionalise graphene for product applications, in an effort to accelerate commercialisation of graphene-based formulations in various different industries.

the agreement, which runs through to 31 december 2025, will see the parties exploring graphene for further commercial applications in battery cells, composites, coatings and thermal materials, among others. the collaboration will also cover knowledge sharing between the parties."

holy moly, i haven't had time to fully p**** this but this seems like it could be transformative for little old haydale!

I do agree that the cash burn is slightly alarming, and a raise would be a disaster. However the fact that the volume of brakes manufactured has increased by >80% gives me some encouragement that the capacity ramp up is working, albeit behind schedule and I think they should be able to mop up the overspend.

The new CFO and COO should help keep things on track as well.

Plus, exciting to have the titbit of further contract announcements dangled in front of us! If customers are prepared to place orders, well that's the ultimate endorsement really.

Talk about practicing what you preach! Huge show of co-ordinated confidence

A couple of thoughts on today's announcements...

i) H1 revenue of £4.4m vs a mktcap of £3.41m - clearly the market is worried about another fundraise but between growing revenue, growing gross margins and shrunken cost-base another fundraise is likely to be further away than expected

ii) "This division is now the manufacturing arm of sister company Light Science Technologies - with the first production batch of sensorGROW successfully running through the UK Circuits' facility during the Period."

They have moved to a more vertically integrated strategy for manufacturing, and are producing sensorGROWs - this will be beneficial for gross margins, plus it's good to hear there is demand for sensorGROWs

iii) "Initial field trials increased crop growth by 40% in December 2022 - particularly useful given the cold ground and the poor light in glasshouses at that time of year, further highlighting commercial opportunities and the Group's ability to help extend the growing season."

This is huge. Due to their fixed contracts, companies like Zenith tend to import produce over winter - rather than grow it themselves - meaning profit margins are much tighter and agri-labour is underutilised. As we get back to more normalised energy prices and see climate change increase seasonal variability the business case for moving to Controlled Environmental Agriculture grows and grows.

iv) Therefore, the Group's broader strategy remains on creating partnerships globally within this division, enabling it to develop a portfolio of clients to include markets that have been less impacted by the energy crisis.

The fact they have recognised and are acting on the need to pursue distribution partnerships rather than selling directly is also very encouraging - this should help them leverage existing distribution channels and reach more international customers

Overall, between the lines there is a lot of encouraging information in this trading update.

I got 50% of my requested allocation. I can't deny being a tad disappointed, but at the same time I'm glad to now own a small slice of the ever more exciting SRT pie.

They raised the full £750k through PrimaryBid so I guess they were oversubscribed. Very good news if true.

No comms from PrimaryBid yet which is frustrating, I want to know how much I've been allocated.